Insiders · Profile

Kemble George

Director at Sagimet Biosciences. Filing since 19 Jul 2024. CIK 0001858176

Company
Date
Role
Action
Shares
Amount
Of holding
14 Aug 2026
Director
Sold on a plan
350,987
$3.59M
85.0%
11 Aug 2026
Director
Sold on a plan
20,206
$201.15K
24.5%
20 Jul 2026
Director
Sold on a plan
18,844
$140.53K
23.3%
20 Nov 2025
Executive Chairman
Sold on a plan
37,688
$289.98K
31.8%
23 Jul 2024
Executive Chairman
Sold on a plan
23,625
$74.83K
16.6%
19 Jul 2024
Executive Chairman
Sold at will
14,062
$43.60K
9.0%
6 decisions on file.